Shubha Bhat

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 25

Top Topics

Ulcerative Colitis

Top Venues

The Annals of pharmacotherapy

Inflammatory bowel diseases

Current gastroenterology reports

Crohn's & colitis 360

This page only lists publications with an associated author ORCID identifier.

Publications

David K Choi, Michelle Becker, Marina Ivanov, Shubha Bhat
Etrasimod: A Sphingosine-1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis. The Annals of pharmacotherapy (2024)
David K Choi, Hilary Sheridan, Shubha Bhat
Mirikizumab: A New Therapeutic Option for the Treatment of Ulcerative Colitis. The Annals of pharmacotherapy (2024)
Anthony Angyal, Shubha Bhat
Biosimilars in IBD: What Every Clinician Needs to Know. Current gastroenterology reports 26 (3) (2024)
Anthony Angyal, Shubha Bhat
Biosimilars in IBD: What Every Clinician Needs to Know. Current gastroenterology reports 26 (3) (2024)
David K Choi, Michelle Becker, Marina Ivanov, Shubha Bhat
Etrasimod: A Sphingosine-1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis. The Annals of pharmacotherapy (2024)
Anthony Angyal, Shubha Bhat
Biosimilars in IBD: What Every Clinician Needs to Know. Current gastroenterology reports (2024)
Shubha Bhat
Optimizing Medication Access and Use in Inflammatory Bowel Disease: The Roles and Impact of Clinical Pharmacists and Pharmacy Technicians. Crohn's & colitis 360 5 (2) (2023)
Shubha Bhat, Ruishen Lyu, Mitali Agarwal, Michelle Becker, Richard Bloomfeld, David H Bruining, Benjamin L Cohen, Marina Ivanov, Jonathan A Leighton, Alyssa P Stewart, Lindsay Trocke, Stacy S Tse, Ryan C Ungaro, Byron P Vaughn, Miguel Regueiro, Erick Sokn, Florian Rieder
Defining the Roles of Inflammatory Bowel Disease Clinical Pharmacists in the United States: A Systematic Review and National RAND/UCLA Consensus. Inflammatory bowel diseases (2023)
Shubha Bhat
Optimizing Medication Access and Use in Inflammatory Bowel Disease: The Roles and Impact of Clinical Pharmacists and Pharmacy Technicians. Crohn's & colitis 360 5 (2) (2023)
Shubha Bhat, Benjamin Click, Miguel Regueiro
Safety and Monitoring of Inflammatory Bowel Disease Advanced Therapies. Inflammatory bowel diseases (2023)
Shubha Bhat, Florian Rieder
Hypoxia-Inducible Factor 1-Alpha Stabilizers in the Treatment of Inflammatory Bowel Diseases: Oxygen as a Novel IBD Therapy? Journal of Crohn's & colitis 16 (12) (2022)
David K Choi, Hilary Sheridan, Shubha Bhat
Risankizumab-rzaa: A New Therapeutic Option for the Treatment of Crohn's Disease. The Annals of pharmacotherapy (2022)
Shubha Bhat, Maitri Patel, Kristine Duly, David K Choi
Adalimumab-Adbm: The First Interchangeable Biosimilar for the Treatment of Inflammatory Diseases. The Annals of pharmacotherapy 56 (12) (2022)
Shubha Bhat, David Nunes
Pharmacist-Managed Helicobacter pylori Treatment Service Within a Gastroenterology Clinic: Workflow and Real-World Experiences. The Annals of pharmacotherapy (2021)
Shubha Bhat, Freddy Caldera, Francis A Farraye
Barriers to Administering Vaccines in Inflammatory Bowel Disease Centers. Inflammatory bowel diseases 27 (8) (2021)
Naweid Maten, Miranda E Kroehl, Danielle F Loeb, Shubha Bhat, Taylor Ota, Sarah J Billups, Lisa M Schilling, Simeon Heckman, Crystal Reingardt, Katy E Trinkley
An evaluation of clinical decision support tools for Patient Health Questionnaire-9 administration. The mental health clinician 11 (5) (2021)
David Choi, Alyssa P Stewart, Shubha Bhat
Ozanimod: A First-in-Class Sphingosine 1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis. The Annals of pharmacotherapy (2021)
Shubha Bhat, Taha Qazi, Francis A Farraye
Managing infliximab infusions after a drug holiday. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 78 (18) (2021)
Ji Yoon Kim, Shubha Bhat
Safety of Rapid Infliximab Biosimilar Infusions in Patients With Inflammatory Bowel Disease. The Annals of pharmacotherapy (2021)
Alison Lh Quinn, Shubha Bhat, James C Lee
Effect of CYP2C9 *11/*11 genotype on initial and long-term warfarin dose requirement and therapeutic response. Pharmacogenomics 21 (18) (2020)
Michelle R Paulsen, Nikitha R Patel, Carol Sulis, Francis A Farraye, Shubha Bhat
Human Papillomavirus, Herpes Zoster, and Hepatitis B Vaccinations in Immunocompromised Patients: An Update for Pharmacists. Journal of pharmacy practice 34 (6) (2020)
Shubha Bhat, Amanuel Kehasse
Additional clinical pharmacists roles during COVID-19. Journal of the American College of Clinical Pharmacy : JACCP (2020)
Stephanie A Flowers, Shubha Bhat, James C Lee
Potential Implications of Gut Microbiota in Drug Pharmacokinetics and Bioavailability. Pharmacotherapy 40 (7) (2020)
Shubha Bhat, Miranda Kroehl, Brian Maniga, Alina Navarro, Angela M Thompson, H Mindy Lam, Katy E Trinkley
Patient Outreaches for Clinical Pharmacy Services: A Population Health Management Program Assessment. Journal of pharmacy practice 34 (1) (2019)
Shubha Bhat, Mayank Kansal, George T Kondos, Vicki Groo
Outcomes of a Pharmacist-Managed Heart Failure Medication Titration Assistance Clinic. The Annals of pharmacotherapy 52 (8) (2018)